Table 1 The demographics of patients
|  |  | Total (N = 60) | Non-relief (n = 9) | Relief (n = 51) | P value |
|---|---|---|---|---|---|
Gender (n,%) | Female | 52 (86.7) | 9 (100) | 43 (84.31) | 0.024 |
| Â | Male | 8 (13.3) | 0 (0) | 8 (15.69) | Â |
Age | Median (P25-P75) | 47 (36.5 – 51.75) | 40 (33 – 50.5) | 47 (38 – 53) | 0.722 |
|  | Mean ± SD | 45.2 ± 10.97 | 42.89 ± 10.96 | 45.61 ± 11.16 |  |
BMI | Median (P25-P75) | 22.48 (21.26 – 23.99) | 21.78 (18.598 – 23.05) | 22.58 (21.34 – 24.28) | 0.100 |
|  | Mean ± SD | 22.62 ± 2.76 | 20.94 ± 3.3 | 22.92 ± 2.75 |  |
Education | Primary | 6 (10) | 0 (0) | 6 (11.76) | 0.495 |
| Â | Medium | 32 (53.3) | 7 (77.78) | 25 (49.02) | Â |
| Â | Higher | 22 (36.7) | 2 (22.22) | 20 (39.22) | Â |
IBS-SSS | Median (P25-P75) | 225 (156.25 – 275) | 225 (162.5 – 342.5) | 225 (125 – 275) | 0.445 |
(Baseline) | Mean ± SD | 225.17 ± 92.296 | 245.56 ± 86.05 | 221.57 ± 86.89 |  |
Basic disease * | No | 56 (93.3) | 9 (100) | 47 (92.16) | 0.347 |
| Â | Yes | 4 (6.7) | 0 (0) | 4 (7.84) | Â |
Drug-related side effects # | No | 44 (73.3) | 8 (88.89) | 36 (70.59) | 0.360 |
Yes | 16 (26.7) | 1 (11.11) | 15 (29.41) | Â |